Cardiovascular biomarkers in feline hypertrophic cardiomyopathy phenotype: evidence from the last decade
Authors:
Open Access
- 17 July 2026
- journal article
- review article
- Published by Springer Nature in Veterinary Research Communications
- Vol. 50 (5) , 465
Abstract
The hypertrophic cardiomyopathy (HCM) phenotype is the most common feline cardiovascular condition, characterized by myocardial hypertrophy and variable hemodynamic changes, with diagnosis primarily based on echocardiography. However, cardiovascular biomarkers have gained increasing importance in the diagnostic assessment of the HCM phenotype. This systematic review aimed to evaluate the utility of cardiovascular-related biomarkers in the diagnosis of HCM in cats, in order to determine their clinical potential and utility. A systematic search was conducted in PubMed, Scopus, and Web of Science over a last decade (January 2015 – June 2025). Study selection was performed by a single reviewer, and risk-of-bias assessment by two reviewers using the Joanna Briggs Institute (JBI) tools. Studies providing relevant data on the use of cardiovascular biomarkers in cats with the HCM phenotype were included. Data regarding study design, population characteristics, biomarker type, and clinical associations were extracted and analyzed. Out of 220 initially screened studies, 63 met the inclusion criteria and the majority were considered of high methodological quality with low risk of bias. The most frequently reported biomarkers were N-terminal pro–B-type natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI), both commonly associated with clinical status, echocardiographic findings, and prognostic risk. Other emerging biomarkers, including molecular and genetic markers related to myocardial remodeling and fibrosis, demonstrated potential clinical utility, although further investigation is still required. Overall, despite robust scientific evidence, biomarkers play an adjunctive role in the evaluation of the feline HCM phenotype. Echocardiography remains the gold standard for definitive diagnosis.Keywords
Funding Information
- Universidade Federal de Minas Gerais
This publication has 111 references indexed in Scilit:
- Left ventricular outpouching with an intracavitary thrombus in a cat with end‐stage hypertrophic cardiomyopathyVeterinary Record Case Reports, 2025
- Metabolic Abnormalities and Reprogramming in Cats with Naturally Occurring Hypertrophic CardiomyopathyESC Heart Failure, 2024
- Predicting Development of Hypertrophic Cardiomyopathy and Disease Outcomes in CatsVeterinary Clinics of North America: Small Animal Practice, 2023
- Hypertrophic Cardiomyopathy–Advances in Imaging and Diagnostic StrategiesVeterinary Clinics of North America: Small Animal Practice, 2023
- MicroRNA profiling of the feline left heart identifies chamber-specific expression signatures in health and in advanced hypertrophic cardiomyopathyJournal of Molecular and Cellular Cardiology Plus, 2023
- Clinical findings associated with N‐terminal pro‐B‐type natriuretic peptide measurement in dogs and cats attending first opinion veterinary practicesVeterinary Record, 2021
- Feline Cardiogenic Arterial ThromboembolismVeterinary Clinics of North America: Small Animal Practice, 2017
- Asymptomatic Hypertrophic CardiomyopathyVeterinary Clinics of North America: Small Animal Practice, 2017
- NT-proBNP measurement fails to reliably identify subclinical hypertrophic cardiomyopathy in Maine Coon catsJournal of Feline Medicine and Surgery, 2010
- Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathyJournal of Veterinary Cardiology, 2009